Not So Secret

Just how private is your DNA, asks an article in Salon. The story covers the pros and cons of inadvertently making your DNA public by buying personal genome services, for instance, and how your code might eventually be misused. "The promise of these tests includes drugs that may someday be tailored to treat your illnesses," the story says. "The peril is that your personal data could circulate more widely than you expect." Blaine Bettinger, who is a customer of 23andMe, was interviewed, and he's a bit more optimistic about data handling.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.